First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter.
Belohlavkova P, Steinerova K, Karas M, Skoumalova I, Rohon P, Indrak K, Voglova J, Vrbacky F, Cmunt E, Necasova T, Kristkova Z, Trneny M, Zak P, Papajik T, Faber E.
Belohlavkova P, et al. Among authors: vrbacky f.
Leuk Res. 2019 Jun;81:67-74. doi: 10.1016/j.leukres.2019.04.011. Epub 2019 Apr 24.
Leuk Res. 2019.
PMID: 31051328